SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (2524)5/16/1998 11:06:00 PM
From: Richard Ogier  Respond to of 9523
 
Re: Doesn't Pfizer have any capacity constraints.

I'm sure they can increase their capacity as needed, but there
might be a few months lag behind demand if the demand grows
too fast.

It could be that weekly scripts would be higher if stores didn't
run out of Viagra. If so, then the number of scripts should grow
even faster than one would estimate by looking at the curve.

Richard



To: blankmind who wrote (2524)5/17/1998 10:57:00 AM
From: BigKNY3  Read Replies (2) | Respond to of 9523
 
Blankmind <<- Doesn't Pfizer have any capacity constraints?- I mean, scrips are approaching the 300,000 a week mark, and won't Pfizer become capacity constrained at some point? >>

I believe that PFE was producing Viagra at risk for months prior to FDA approval in anticipation of a large demand.

Another example of a great company with superior management skills.

BigKNY3


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News